Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit.

Toyoda H, Hiraoka A, Ochi H, Tsuji K, Tajiri K, Tani J, Tada T, Okubo T, Atsukawa M, Hirooka M, Itobayashi E, Hatanaka T, Kariyama K, Ishikawa T, Kuroda H, Takaguchi K, Kosaka H, Kawada K, Kakizaki S, Yada Y, Ogawa C, Nishimura T, Yasuda S, Deguchi A, Morishita A, Itokawa N, Arai T, Tsutsui A, Naganuma A, Enomoto H, Kaibori M, Nouso K, Hiasa Y, Kumada T, Akita T, Tanaka J, Johnson PJ

Open source

DOI: 10.1200/cci-24-00175
Published: 2025 May
Container: JCO clinical cancer informatics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/cci-24-00175,
  title = {Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit.},
  author = {Toyoda H and Hiraoka A and Ochi H and Tsuji K and Tajiri K and Tani J and Tada T and Okubo T and Atsukawa M and Hirooka M and Itobayashi E and Hatanaka T and Kariyama K and Ishikawa T and Kuroda H and Takaguchi K and Kosaka H and Kawada K and Kakizaki S and Yada Y and Ogawa C and Nishimura T and Yasuda S and Deguchi A and Morishita A and Itokawa N and Arai T and Tsutsui A and Naganuma A and Enomoto H and Kaibori M and Nouso K and Hiasa Y and Kumada T and Akita T and Tanaka J and Johnson PJ},
  year = {2025},
  journal = {JCO clinical cancer informatics},
  doi = {10.1200/cci-24-00175},
  url = {https://doi.org/10.1200/cci-24-00175}
}

RIS

TY  - JOUR
TI  - Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit.
AU  - Toyoda H
AU  - Hiraoka A
AU  - Ochi H
AU  - Tsuji K
AU  - Tajiri K
AU  - Tani J
AU  - Tada T
AU  - Okubo T
AU  - Atsukawa M
AU  - Hirooka M
AU  - Itobayashi E
AU  - Hatanaka T
AU  - Kariyama K
AU  - Ishikawa T
AU  - Kuroda H
AU  - Takaguchi K
AU  - Kosaka H
AU  - Kawada K
AU  - Kakizaki S
AU  - Yada Y
AU  - Ogawa C
AU  - Nishimura T
AU  - Yasuda S
AU  - Deguchi A
AU  - Morishita A
AU  - Itokawa N
AU  - Arai T
AU  - Tsutsui A
AU  - Naganuma A
AU  - Enomoto H
AU  - Kaibori M
AU  - Nouso K
AU  - Hiasa Y
AU  - Kumada T
AU  - Akita T
AU  - Tanaka J
AU  - Johnson PJ
PY  - 2025
JO  - JCO clinical cancer informatics
DO  - 10.1200/cci-24-00175
UR  - https://doi.org/10.1200/cci-24-00175
ER  -

APA

H, T., A, H., H, O., K, T., K, T., J, T., T, T., T, O., M, A., M, H., E, I., T, H., K, K., T, I., H, K., K, T., H, K., K, K., S, K., Y, Y., C, O., T, N., S, Y., A, D., A, M., N, I., T, A., A, T., A, N., H, E., M, K., K, N., Y, H., T, K., T, A., J, T., & PJ, J. (2025). Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit.. JCO clinical cancer informatics. https://doi.org/10.1200/cci-24-00175

Source records

pubmed · retrieved 2026-09-26T19:58:52.430Z